Background {#Sec1}
==========

Nontraumatic convexal subarachnoid hemorrhage (cSAH) is a rare presentation of subarachnoid hemorrhage (SAH) localized to one or few sulci of the brain \[[@CR1]\]. Various vascular and nonvascular causes of cSAH have been proposed \[[@CR2]\]. According to previous studies, internal carotid artery (ICA) stenosis or occlusion is a common etiology of cSAH, and nearly all cSAH cases in those studies were reported to be associated with ipsilateral acute ischemic stroke \[[@CR3]--[@CR9]\]. To our knowledge, only one case of embolic stroke associated with contralateral cSAH has been reported \[[@CR10]\]. We report two cases of acute ischemic stroke with contralateral cSAH.

Case presentation {#Sec2}
=================

Case 1 {#Sec3}
------

A 68-year-old man with a history of smoking and hypertension was admitted to our hospital for right-sided weakness and aphasia. On admission, his blood pressure was 170/108 mmHg. Neurologic examination showed right hemiplegia, facial paralysis and aphasia. Brain computed tomography (CT) showed a right parietal cSAH (Fig. [1](#Fig1){ref-type="fig"}a). Moreover, results from magnetic resonance imaging (MRI) T2-weighted fluid-attenuated inversion recovery were compatible with cSAH, which was localized to the sulcus in the right parietal lobe (Fig. [1](#Fig1){ref-type="fig"}b), Diffusion-weighted imaging was performed and showed hyperintense lesions in the distribution of the left middle cerebral artery (Fig. [1](#Fig1){ref-type="fig"}c). Further evaluation with CT-angiography showed occlusion of the left ICA and compensatory flow from the right ICA via the anterior communicating artery (Fig. [1](#Fig1){ref-type="fig"}d and e). Laboratory tests, including evaluations for inflammation, coagulation parameters, autoantibodies and neoplastic markers, were all unremarkable. Cerebral amyloid angiopathy (CAA) was excluded because of the absence of microbleeds on susceptibility-weighted imaging. There was no evidence of posterior reversible encephalopathy syndrome, without typical parieto-occipital vasogenic edema on MRI. Moreover, color Doppler ultrasonography showed *atherosclerotic plaque* formation *in the* bilateral *carotids and lower extremities.* Thus, the diagnosis of large artery atherosclerosis stroke was confirmed and full anti-atherosclerosis therapy was initiated (aspirin and atorvastatin). At 3 months' follow-up, the patient had residual right-side limbs weakness and mild disability (modified Rankin Scale 2).Fig. 1A 68-year-old male patient with left ICA occlusion and acute ischemic stroke with contralateral cSAH. **a** CT showed SAH on the right parietal convexity. **b** T2-weighted fluid-attenuated inversion recovery MRI confirmed a right parietal SAH. **c** Diffusion-weighted imaging showed high intensity in the region of the left middle cerebral artery. CT-angiography demonstrated occlusion of the left ICA (arrow) **d** and compensatory flow from the right ICA via the anterior communicating artery **e**

Case 2 {#Sec4}
------

A 56-year-old woman with a history of untreated rheumatic heart disease for 20 years developed left-sided weakness associated with headache for 2 days. There was no history of hypertension, diabetes or hyperlipidemia. Her blood pressure at presentation was 91/58 mmHg. On neurological examination, she was somnolent with a binocular gaze to the right side. Her left limb muscle strength was grade 0/5 with hyperreflexia and positive pathological signs after hospitalization. CT revealed a left parietal cSAH (Fig. [2](#Fig2){ref-type="fig"}a). MRI with diffusion-weighted imaging confirmed the diagnosis of acute right cerebral hemisphere infarction and left parietal cSAH (Fig. [2](#Fig2){ref-type="fig"}b and c), without signs of microbleeds on susceptibility-weighted imaging. Digital subtraction angiography performed the next day showed right ICA occlusion (Fig. [2](#Fig2){ref-type="fig"}d and e). Laboratory findings revealed no evidence of vasculitis, infections, and coagulation disorders. Transthoracic echocardiography showed rheumatic heart disease with severe aortic stenosis and decreased left ventricular diastolic function. The ischemia was classified as ICA occlusion due to cardioembolic stroke. Warfarin was initiated after 2 weeks. Three months later, she underwent elective aortic valve replacement and continued long-term warfarin therapy. She could self-care after a follow-up period of 6 months and had modified Rankin Scale of 2.Fig. 2A 56-year-old female patient with cSAH due to cardioembolic stroke. **a** CT demonstrated a left parietal SAH. **b** T2-weighted fluid-attenuated inversion recovery MRI showed high-signal intensity on the left parietal convexity. **c** Diffusion-weighted imaging demonstrated acute ischemia in the right middle cerebral artery region. Digital subtraction angiography showed occlusion of the right ICA (**d**), and compensatory flow from the ipsilateral anterior cerebral artery via the leptomeningeal artery (**e**)

Discussion and conclusions {#Sec5}
==========================

Nontraumatic SAH is mainly caused by aneurysm rupture, but not all cases have an aneurysmal origin \[[@CR11]\]. cSAH is a rare and heterogeneous entity, and is characterized by bleeding along the cortical convexity. The prevalence of cSAH is reported to be 5--18% of all spontaneous SAH \[[@CR1], [@CR7], [@CR12]--[@CR14]\]. Diverse causes of cSAH have been described including CAA, reversible cerebral vasoconstriction syndrome (RCVS), posterior reversible encephalopathy syndrome, ICA stenosis or occlusion, cerebral venous thrombosis, drug misuse, vasculitis, vascular malformation, brain tumors and abscesses \[[@CR1], [@CR2], [@CR12]\]. cSAH may occur simultaneously with acute ischemic stroke, but this co-occurrence is particularly rare. There are various reasons for this association, such as ICA stenosis or occlusion, artery dissection, RCVS, CAA, and cardioembolism \[[@CR3]--[@CR9], [@CR15]\]. However, the most common cause of cSAH with acute ischemic stroke is ICA stenosis or occlusion \[[@CR7]\]. Moreover, cSAH has been described to occur invariably on the side with acute ischemic stroke, and it is notably unusual for cSAH to occur on the opposite side of the infarct territory. To date, there have been few reports about infarction with contralateral cSAH caused by RCVS, ICA dissection, embolic stroke of undetermined source, and CAA \[[@CR8]--[@CR10], [@CR15]\]. This paper presented two cases of acute ischemic stroke with contralateral cSAH due to ICA atherosclerotic occlusion and cardioembolic stroke, respectively.

The pathophysiology of the association between acute ischemic stroke and cSAH is not fully understood. The current leading theory suggests that cSAH may occur in the setting of severe atherosclerotic stenosis or large artery occlusion, potentially by a mechanism similar to hemorrhage caused by moyamoya disease \[[@CR2], [@CR16]\], the acute alteration in hemodynamics may lead to cSAH. Plaque rupture leads to further atherothrombotic narrowing, while acute hypertension results in the spontaneous rupture of fragile collateral vessels \[[@CR2], [@CR7]\]. Further, another theory suggests that emboli to marginally perfused vessels can cause necrosis and rupture \[[@CR3], [@CR16]\]. In case 1 in our study, ICA occlusion had an influence on the hemispheric cerebral blood flow of both the occluded and contralateral sides. We speculate that increased contralateral leptomeningeal flow towards the occluded side may have caused cSAH. The establishment of collateral circulation can lead to hemodynamic changes on the contralateral side and leptomeningeal anastomoses on the cerebral surface may have served as a link for this increase in cerebral blood flow \[[@CR17]\]. Moreover, occlusion on the ischemic side may have led to the dilatation of the contralateral vasculature as a compensatory mechanism. This dilatation beyond physiological limits increases vessel fragility, and finally causes the ruptures of small vessels. Regarding case 2, the hemodynamic changes due to occlusion of ICA may also have participated in the pathogenesis of cSAH. In addition, we considered that emboli from the heart may have clogged the ipsilateral vessels and caused infarction. Moreover, these emboli may have damaged already highly dilated contralateral vasculature in the arterial border zone, leading to cSAH. Nevertheless, the precise mechanism by which this occurs remains unclear.

Generally, antithrombotic treatment is suggested for patients with infarction. However, the increased risk of cerebral hemorrhage or SAH due to antithrombotic therapy cannot be ignored \[[@CR18]\]. There is no consensus on the treatment for acute ischemic stroke co-occurring with cSAH. Few studies suggest that antithrombotic agents are safe for patients with this condition who have large artery stenosis or occlusion \[[@CR5], [@CR7]--[@CR9]\]. Antiplatelet or anticoagulation drugs did not seem to influence the outcome in our two cases. Both patients had a good prognosis which is consistent with the literature \[[@CR3], [@CR5], [@CR7]--[@CR9]\].

Our case reports suggest that contralateral cSAH can occur alongside acute ischemic stroke caused by atherosclerotic ICA occlusion and cardioembolic stroke. cSAH did not lead to poorer outcomes in our patients. Future research should focus on establishing a standard treatment strategy for this condition.
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